<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">urovest</journal-id><journal-title-group><journal-title xml:lang="en">Urology Herald</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник урологии</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2308-6424</issn><publisher><publisher-name>Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2308-6424-2023-11-1-80-88</article-id><article-id custom-type="elpub" pub-id-type="custom">urovest-672</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>Pathomorphism of buccal grafts used in surgery of extensive bulbar urethral strictures: immunohistochemical analysis</article-title><trans-title-group xml:lang="ru"><trans-title>Иммуногистохимический анализ патоморфоза буккальных трансплантатов, используемых при хирургии протяжённых стриктур бульбозной уретры</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7706-8925</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Митусов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mitusov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Валерий Викторович Митусов — доктор медицинских наук, доцент; профессор кафедры урологии и репродуктивного здоровья человека (с курсом детскойурологии-андрологии),</p><p>г. Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Valeriy V. Mitusov — M.D., Dr.Sc.(Med), Assoc.Prof.(Docent); Prof., Dept. of Urology, Pediatric Urology and Reproductive Health, </p><p>Rostov-on-Don</p></bio><email xlink:type="simple">mvv55@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0542-6900</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воронова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Voronova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Владимировна Воронова ― ассистент кафедры судебной медицины,</p><p>г. Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Olga V. Voronova ― M.D.; Assist.Prof., Dept. Forensic Medicine, </p><p>Rostov-on-Don</p></bio><email xlink:type="simple">voronova.olga_jaba@icloud.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8486-9357</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глухов</surname><given-names>В. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Glukhov</surname><given-names>V. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Владимир Павлович Глухов — кандидат медицинских наук, доцент; доцент кафедры урологии и репродуктивного здоровья человека (с курсом детской урологии-андрологии),</p><p>г. Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Vladimir P. Glukhov — M.D., Cand.Sc.(Med), Assoc.Prof. (Docent); Assoc.Prof., Dept. of Urology, Pediatric Urology and Reproductive Health,</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">docc.gvp@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5642-4521</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильев</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasiliev</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Олег Николаевич Васильев ― доктор медицинских наук; доцент кафедры урологии и репродуктивного здоровья человека (с курсом детской урологииандрологии),  заведующий урологическим отделением клиники,</p><p>г. Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Oleg N. Vasilyev — M.D., Dr.Sc.(Med); Assoc.Prof. (Docent), Dept. of Urology, Pediatric Urology and Reproductive Health, </p><p>Head, Urology Division, </p><p>Rostov-on-Don</p></bio><email xlink:type="simple">vasilyev_on@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3270-8420</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Амирбеков</surname><given-names>Б. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Amirbekov</surname><given-names>B. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бейкес Ганифаевич Амирбеков ― кандидат медицинских наук; врач-уролог консультативной поликлиники,</p><p>г. Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Beikes G. Amirbekov ― M.D., Cand.Sc.(Med); Urologist, Outpatients Clinic,</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">amir_uro@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2623-6137</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лоскутов</surname><given-names>М. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Loskutov</surname><given-names>M. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михаил Георгиевич Лоскутов ― врач-уролог урологического отделения клиники,</p><p>г. Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Micheal G. Loskutov ― Urologist, urological Department,</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">mikhail-Loskutov1612@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University;&#13;
Rostov State Medical University Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>07</day><month>04</month><year>2023</year></pub-date><volume>11</volume><issue>1</issue><fpage>80</fpage><lpage>88</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Mitusov V.V., Voronova O.V., Glukhov V.P., Vasiliev O.N., Amirbekov B.G., Loskutov M.G., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Митусов В.В., Воронова О.В., Глухов В.П., Васильев О.Н., Амирбеков Б.Г., Лоскутов М.Г.</copyright-holder><copyright-holder xml:lang="en">Mitusov V.V., Voronova O.V., Glukhov V.P., Vasiliev O.N., Amirbekov B.G., Loskutov M.G.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.urovest.ru/jour/article/view/672">https://www.urovest.ru/jour/article/view/672</self-uri><abstract><sec><title>Introduction</title><p>Introduction. The adverse effects of urine on unadapted tissues are known. This is also entirely relevant for buccal grafts used in augmentation urethroplasty, where these effects have not been thoroughly studied so far.</p></sec><sec><title>Objective</title><p>Objective. To assess the ongoing pathomorphosis in buccal grafts used for urethral augmentation of extensive strictures in the bulbous region and to evaluate how much urine influences their histological transformation following surgery.</p></sec><sec><title>Materials &amp; methods</title><p>Materials &amp; methods. The study included 15 patients with extensive strictures of the bulbous urethra, who underwent a two-stage augmentation urethroplasty with buccal grafts. The grafts pathomorphosis was studied 6 months after the first surgery stage where urethrotomy had been performed with graft augmentation of the dorsal semicircle and the formation of distal and proximal neomeatuses. Natural urination through the latter was restored on days 14 – 20 following the surgery. During the second stage, six months later, urethral tubularisation was performed with two preliminary biopsies of the proximal and distal segments of the grafts implanted in the areas of the neomeatuses formed earlier. The distal area of the graft had no contact with urine, while this contact has occurred in the proximal segment since restoration of natural urination. In biopsy specimens, pathomorphosis of the grafts was studied using immunohistochemical markers: vimentin, clone SRL33; CD34, clone QBEnd/10; MSA HHF-35; СD3, clone LN10; Bcl-2, clone bcl-2\100\D5; CK-HMW 34BE-12.</p></sec><sec><title>Results</title><p>Results. It was found that inflammation was minimal in areas of grafts implanted that had no contact with urine, while in areas where such contact occurred it was verified to be pronounced even 6 months after the operation. On the submucosal level, this was manifested by an uneven arrangement of collagen fibers, a dysplastically developed vascular network, uneven proliferation of the endothelium with swelling and loss of cellular connectivity, in contrast to areas where there was no contact with urine. In such areas, the graft submucosa had a dense collagen framework with organized microvasculature and uniform epithelial surface.</p></sec><sec><title>Conclusion</title><p>Conclusion. The impact of urine on buccal grafts used in augmentation urethroplasty is characterised by the disorganisation of its collagen framework, with a pronounced inflammatory component and the “reactivity” of the epithelial lining to the “toxic agent” that persists even 6 months after surgery. This may underlie the risk of a stenosis relapse in the proximal anastomosis area. </p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Введение</title><p>Введение. Неблагоприятное воздействие мочи на эволюционно неадаптированные ткани известно. В полной мере это относится и к буккальным трансплантатам, применяемым при аугментационных уретропластиках, что до конца не изучено.</p></sec><sec><title>Цель исследования</title><p>Цель исследования. Оценить патоморфоз буккальных трансплантатов, применяемых при аугментации уретры по поводу протяжённых стриктур бульбозного отдела и значимость воздействия мочи на их гистологическую трасформацию после операции.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование включено 15 больных с протяжёнными стриктурами бульбозной уретры, которым выполнена двухэтапная аугментационная уретропластика с использованием буккальных трансплантатов. Изучен патоморфоз трансплантатов через 6 месяцев после проведения первого этапа операции, когда выполнялись уретротомия с аугментацией трансплантатом дорзальной полуокружности уретры и формирование дистального и проксимального неомеатусов. Через последний на 14 – 20-е сутки после операции восстанавливали естественное мочеиспускание. На втором этапе хирургии (через 6 месяцев) осуществляли тубуляризацию уретры с предварительным выполнением двух биопсий из проксимального и дистального сегментов трансплантатов в зонах сформированных неомеатусов. В дистальной зоне трансплантата не было его контакта с мочой, а в проксимальном сегменте такой контакт имел место с момента восстановления естественного мочеиспускания. В биоптатах изучали патоморфоз в трансплантатах с использованием иммуногистохимических маркеров (виментин, клон SRL33; CD34, клон QBEnd/10; MSA HHF-35; СD3, клон LN10; Bcl-2, клон bcl-2\100\D5; CKHMW 34BE-12).</p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что в зонах трансплантатов, где не было контакта с мочой, воспаление было минимальным, а в зонах, где такой контакт происходил, оно верифицировалось как выраженное даже через 6 месяцев после операции. На уровне подслизистой основы это проявлялось неравномерным расположением коллагеновых волокон, диспластично развитой сосудистой сетью, неравномерной пролиферацией эндотелия с набуханием и потерей межклеточных связей в отличие от зон, где контакта с мочой не было. В таких участках подслизистая основа трансплантата имела плотный коллагеновый каркас с организованным микроциркуляторным руслом и равномерной эпителиальной поверхностью.</p></sec><sec><title>Заключение</title><p>Заключение. Воздействие мочи на буккальные трансплантаты, используемые при аугментационных уретропластиках, характеризуется дезорганизацией его коллагенового каркаса, выраженным воспалительным компонентом и «реактивностью» эпителиальной выстилки на «токсический агент» сохраняющейся даже через 6 месяцев после вмешательства, что может лежать в основе риска возникновения рецидива стеноза в зоне проксимального анастомоза. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>протяжённые стриктуры уретры</kwd><kwd>уретропластика</kwd><kwd>патоморфоз буккальных трансплантатов</kwd><kwd>иммуногистохимический анализ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>extensive urethral strictures</kwd><kwd>urethroplasty</kwd><kwd>pathomorphosis</kwd><kwd>buccal grafts</kwd><kwd>immunohistochemical analysis</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Nowadays, the most effective method of treating the extended strictures of the spongiose urethra is augmentation urethroplasty, where fragments of the oral mucosa are used as a graft [1–4].</p><p>Currently, there are 5 options for performing such augmentation, which differ in the technique of graft fixation [<xref ref-type="bibr" rid="cit4">4</xref>].</p><p>The frequency of relapses and complications after such operations, regardless of the chosen technique, is 19 – 40%, and the most frequent complications are narrowing in the areas of proximal and distal areas of anastomosis of a graft with a native urethra. In a certain number of cases, contractures occur throughout the graft [5–8].</p><p>In recent years, new academic works appeared – their authors noted that the development of such complications may not be based so much on the surgical technique as on the initial morphological structure of the graft itself and the adverse effect of urine on it [9–13].</p><p>The study aimed to evaluate the pathomorphosis of buccal grafts used for urethral augmentation due to extended bulbar strictures, and the significance of the effect of urine on their histological transformation after surgery.</p></sec><sec><title>Materials and methods</title><p>The study included 15 patients with a median age of 42.5 years who underwent two-stage urethroplasty of extended strictures (4 – 7 cm) of the bulbous urethra using buccal grafts.</p><p>Stage 1 – urethrotomy with augmentation with a dorsal semicircle graft and the formation of two neomeatus. The urethral catheter was placed in the proximal neomeatus for 14 – 20 days, followed by its removal and restoration of natural urination.</p><p>Stage 2 – urethral tubularization, which was performed after 6 months with the preliminary execution of two biopsies from the proximal and distal segments of the engrafted grafts in the areas of the neomeatus formed earlier.</p><p>The study of pathomorphosis in transplants was carried out with an assessment of the stromal and vascular components, the degree of inflammation and the reaction of the epithelial layer using the following immunohistochemical markers (IHC).</p><p>The expression was evaluated by a semi-quantitative method in the following points: 0 – absence, 1 – weak, 2 – moderate, 3 – pronounced reaction of marker-positive cells.</p></sec><sec><title>Results</title><p>Therefore, 6 months after graft implantation, the expression of the IHC marker Vimentin in its stroma in the proximal meatus area was the highest and was assessed as 3-point, and in the distal meatus area, it was moderate – 2 points (Fig. 1).</p><fig id="fig-1"><caption><p>Figure 1. Vimentin expression in the graft: A – proximal fragment (3 points), magn. ×200; B – distal fragment (2 points), magn. ×200 </p></caption><graphic xlink:href="urovest-11-1-g001.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/urovest/2023/1/BFWSTanPwPtKvEpnfCiHGPIoITHGVZtp2fRE9cJ0.jpeg</uri></graphic></fig><p>These results fully correlate with the vascular component assessment data using CD34 markers (Fig. 2) and MSA (Fig. 3), which made it possible not only to verify the overall vascular structure but also to evaluate the smooth muscle framework in the vessels of the graft stroma. The point values of the differences in the study areas were like those in the stroma of the engrafted grafts – 3 and 2 points.</p><fig id="fig-2"><caption><p>Figure 2. CD 34 expression in the graft: A – proximal fragment (3 points), magn. ×200; B – distal fragment (2 points), magn. ×200</p></caption><graphic xlink:href="urovest-11-1-g002.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/urovest/2023/1/5xxez152XNFaGoFBXW9AquayAiIlETbXDLhhaHhp.jpeg</uri></graphic></fig><fig id="fig-3"><caption><p>Figure 3. MSA HHF-35 expression in the graft: A – proximal fragment (3 points), magn. ×200; B – distal fragment (2 points), magn. ×200</p></caption><graphic xlink:href="urovest-11-1-g003.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/urovest/2023/1/wZGq22jOoqLjvfn7KKsce6djyV6dQNVd4FL0wtnT.jpeg</uri></graphic></fig><p>The most convincing data on the effect of urine on the engraftment of buccal proximal ends of grafts were obtained by studying inflammation after 6 months after their fixation at the first stage of urethroplasty. The study of T-lymphocytes in the inflammatory infiltrate was carried out with a CD3 marker, and B-lymphocytes with a Bcl-2 marker.</p><p>In the areas where the graft was not exposed to urine (distal neomeatus), the inflammation was minimal and was rated at 0 points, and in the areas of proximal neomeatus it was characterized as pronounced (3 points) for the T-cell component (Fig. 4) and moderate (2 points) for the B-cell component (Fig. 5).</p><fig id="fig-4"><caption><p>Figure 4. CD3 expression in the graft: A – proximal fragment (3 points), magn. ×100; B) distal fragment (0 points), magn. ×100</p></caption><graphic xlink:href="urovest-11-1-g004.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/urovest/2023/1/pzvx0BgSLAAREbzrz8z9BuUMIWezNC0J9nda9b5J.jpeg</uri></graphic></fig><fig id="fig-5"><caption><p>Figure 5. Bcl-2 expression in the graft: A – proximal fragment (2 points), magn. ×200; B – distal fragment (0 points), magn. ×200</p></caption><graphic xlink:href="urovest-11-1-g005.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/urovest/2023/1/3ZTkOn6KTxNA75ThZG7ZsjiZnlonxnZw83FITY8b.jpeg</uri></graphic></fig><p>Changes in the stroma of the grafts, their vascular structure, and the nature of inflammation when exposed to urine and without it on the grafts could not but affect their epithelial structure. This was fully confirmed not only in the assessment of the marker expression by the IHC scores but also in the visual assessment, which is clearly visible on the microphoto (Fig. 6).</p><fig id="fig-6"><caption><p>Figure 6. CK-HMW expression in the graft: A – proximal fragment (1 point), magn. ×100; B – distal fragment (3 points), magn. ×100</p></caption><graphic xlink:href="urovest-11-1-g006.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/urovest/2023/1/1AJZ5A9AlQHKSEtqbhKa5IgTZZzBgAJ8ag4Hp9YJ.jpeg</uri></graphic></fig><p>The IHC marker for assessing changes in the epithelium of transplants was CK-HMW, where its expression in the proximal area was estimated at only 1 point due to pronounced reactive inflammation leading to the epithelial layer stratification, which determined the poor exposure of the marker. In contrast to the distal area, where the expression of the marker reached a value of 3 points due to the absence of inflammation and the presence of a clear uniform structure of the epithelial layer.</p></sec><sec><title>Discussion</title><p>Augmentation urethroplasty with extended spongy urethral strictures can be performed in one or more stages. It is determined by several factors: etiology, localization, and extent, single or multi-focal foci of obstruction, the degree of inflammation in the spongy body, as well as the personal preference of the surgeon when performing this type of intervention [1–4].</p><p>While performing a one-stage intervention, the removal of the urethral catheter is performed on the 14th – 28th day after surgery, and natural urination is restored. From this moment the direct contact of the graft with urine, as a biological medium, takes place in this process.</p><p>The significance of the latter, in the authors’ opinion, undoubtedly influences the graft engraftment process, which may be the basis for the subsequent development of a recurrence of urethral narrowing despite the restored patency of the urethra in this stage of disease treatment [<xref ref-type="bibr" rid="cit6">6</xref>][9–13].</p><p>In real clinical practise, it is impossible to 'track' the morphological changes that occur in the graft itself in patients who underwent simultaneous augmentation urethroplasty.</p><p>In this study, the authors worked with the ongoing morphological transformation in transplants in patients where two-stage interventions were performed by studying morphological changes in 2 areas in the same patient — around the proximal and distal neomeatus. In the proximal neomeatus, contact with urine occurred 2 – 3 weeks immediately after catheter removal, and in the distal one, it was not present for 6 months before the second stage of the operation – urethral tubularization.</p><p>It was found that even 6 months after good graft engraftment according to clinical parameters, which was determined by its appearance, the absence of infiltration sites, scarring and deformation, palpatory 'mobility' and other parameters, histomorphological differences in areas where early contact with urine and without it took place were significant.</p><p>Thus, in the areas of transplants where there was no contact with urine (distal neomeatus), inflammation was minimal, and in the areas of proximal neomeatus, it was verified as expressed by T-cell reaction (CD3 marker) and moderate by B-lymphocytes (Bcl-2 marker).</p><p>It was extremely important to assess the nature of histological differences in the structure of the submucosal base, which clinically plays the main role in the graft during augmentation urethroplasty, regardless of the technique chosen for its implementation.</p><p>Evaluation of the stromal component of the submucosal base in transplants where its contact with urine occurred quite early, even 6 months after surgery, an uneven arrangement of collagen fibres (Vimentin marker) with a dysplastically developed vascular network, uneven endothelial proliferation with swelling, and loss of intercellular connections (CD34 and MSA markers) was revealed. In graft biopsies removed a few centimeters distal, in areas where there was no early contact with urine, the submucosal base had a dense collagen framework with an organised microcirculatory bed, which was proven by the degree of expression of the IHC markers used under microscopy.</p><p>The presented data fully correlated with the nature of the detected differences in the epithelial layer of the grafts of the areas studied (marker CKHMW). Thus, the pronounced expression of the IHC marker in the proximal neomeatus area against a discretely weak reaction in the epithelial layer in the distal neomeatus area was indicative, which, undoubtedly, should be regarded as a reaction to the irritating factor, which is urine.</p></sec><sec><title>Conclusion</title><p>The effect of urine on buccal grafts used in augmentation urethroplasty is characterized by the disorganization of its collagen framework with a pronounced inflammatory component and the “reactivity” of the epithelial lining, which persists even 6 months after the intervention. The revealed differences in the pathomorphosis of engrafted transplants with early exposure to urine and without it can be one of the important determining factors for the risk of disease relapse. At the same time, the risk of relapse is higher when a one-stage urethroplasty is performed than in cases where surgery is performed in two stages of extended strictures of the bulbous urethra.</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Синельников Л.М., Протощак В.В., Шестаев А.Ю., Карпущенко Е.Г., Янцев А.А. Стриктура уретры: современное состояние проблемы (Обзор литературы). Экспериментальная и клиническая урология. 2016;2:80-87. eLIBRARY ID: 29899545</mixed-citation><mixed-citation xml:lang="en">Sinelnikov L.M., Protoschak V.V., Shestaev A.Y., Karpushchenko E.G., Yartsev A.A. Urethral stricture: Modern state of the problem (Literature review). Experimental and clinical urology. 2016;2:80-87. (In Russian). eLIBRARY ID: 29899545</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Horiguchi A. Substitution urethroplasty using oral mucosa graft for male anterior urethral stricture disease: Current topics and reviews. Int J Urol. 2017;24(7):493-503. DOI: 10.1111/iju.13356</mixed-citation><mixed-citation xml:lang="en">Horiguchi A. Substitution urethroplasty using oral mucosa graft for male anterior urethral stricture disease: Current topics and reviews. Int J Urol. 2017;24(7):493-503. DOI: 10.1111/iju.13356</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Barbagli G, Balò S, Montorsi F, Sansalone S, Lazzeri M. History and evolution of the use of oral mucosa for urethral reconstruction. Asian J Urol. 2017;4(2):96-101. DOI: 10.1016/j.ajur.2016.05.006</mixed-citation><mixed-citation xml:lang="en">Barbagli G, Balò S, Montorsi F, Sansalone S, Lazzeri M. History and evolution of the use of oral mucosa for urethral reconstruction. Asian J Urol. 2017;4(2):96-101. DOI: 10.1016/j.ajur.2016.05.006</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Поляков Н.В., Кешишев Н.Г., Казаченко А.В., Трофимчук А.Д., Чернышев И.В., Даренков С.П., Аполихин О.И. Оценка эффективности методов буккальной уретропластики при стриктурах мочеиспускательного канала у мужчин. (Обзор литературы). Экспериментальная и клиническая урология. 2019;4:106-113. DOI: 10.29188/2222-8543-2019-11-4-106-113</mixed-citation><mixed-citation xml:lang="en">Polyakov N.V., Keshishev N.G., Kazachenko A.V., Trofimchuk A.D., Chernyshev I.V., Darenkov S.P., Apolikhin O.I. The effectiveness off buccal uretrhoplasty for urethral strictures in men: (Review). Experimental and clinical urology. 2019;4:106-113. (In Russian). DOI: 10.29188/2222-8543-2019-11-4-106-113</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Robine E, Rigaud J, Luyckx F, Le Clerc QC, Madec FX, Bouchot O, Branchereau J. Analyse des taux de succès des urétroplasties pour sténoses de l’urètre bulbaire chez l’homme adulte : revue systématique de la littérature [Analysis of success rates of uretroplasty for adult male bulbar urethral stricture: A systematic review]. Prog Urol. 2017;27(2):49-57. (French). DOI: 10.1016/j.purol.2016.12.003</mixed-citation><mixed-citation xml:lang="en">Robine E, Rigaud J, Luyckx F, Le Clerc QC, Madec FX, Bouchot O, Branchereau J. Analyse des taux de succès des urétroplasties pour sténoses de l’urètre bulbaire chez l’homme adulte : revue systématique de la littérature [Analysis of success rates of uretroplasty for adult male bulbar urethral stricture: A systematic review]. Prog Urol. 2017;27(2):49-57. (French). DOI: 10.1016/j.purol.2016.12.003</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Spilotros M, Sihra N, Malde S, Pakzad MH, Hamid R, Ockrim JL, Greenwell TJ. Buccal mucosal graft urethroplasty in men-risk factors for recurrence and complications: a third referral centre experience in anterior urethroplasty using buccal mucosal graft. Transl Androl Urol. 2017;6(3):510-516. DOI: 10.21037/tau.2017.03.69</mixed-citation><mixed-citation xml:lang="en">Spilotros M, Sihra N, Malde S, Pakzad MH, Hamid R, Ockrim JL, Greenwell TJ. Buccal mucosal graft urethroplasty in men-risk factors for recurrence and complications: a third referral centre experience in anterior urethroplasty using buccal mucosal graft. Transl Androl Urol. 2017;6(3):510-516. DOI: 10.21037/tau.2017.03.69</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Митусов В.В., Коган М.И., Мирзаев З.А., Глухов В.П., Амирбеков Б.Г. Минимизация рисков сужения в зонах анастомозирования буккального графта с нативной уретрой при хирургии протяжённых стриктур спонгиозной уретры у мужчин методом dorsal inlay. Вестник урологии. 2021;9(4):60-69. DOI: 10.21886/2308-6424-2021-9-4-60-69</mixed-citation><mixed-citation xml:lang="en">Mitusov V.V., Kogan M.I., Mirzaev Z.A., Glukhov V.P., Amirbekov B.G. Surgical treatment of extended spongy urethral strictures in men: minimizing the risks of narrowing in the anastomotic zones between the buccal graft and the native urethra using the dorsal inlay technique. Urology Herald. 2021;9(4):60-69. (In Russian). DOI: 10.21886/2308-6424-2021-9-4-60-69</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Коган М.И., Глухов В.П., Ильяш А.В., Митусов В.В., Чибичян М.Б. Сложные стриктуры спонгиозной уретры с многоэтапным лечением: прогнозирование риска рецидива. Экспериментальная и клиническая урология. 2022;1:136-141. DOI: 10.29188/2222-8543-2022-15-1-136-141</mixed-citation><mixed-citation xml:lang="en">Kogan M.I., Glukhov V.P., Ilyash A.V Mitusov V.V., Krasulin V.V., Chibichyan M.B. Complex spongy urethral strictures with multi-stage treatment: predicting the recurrence risk. Experimental and clinical urology. 2022;1:136-141. (In Russian). DOI: 10.29188/2222-8543-2022-15-1-136-141</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Коган М.И., Дементьева И.Ю., Митусов В.В., Глухов В.П., Красулин В.В., Сизякин Д.В., Ильяш А.В. Гистопатологическая оценка эволюции трансплантатов слизистой оболочки ротовой полости, используемых для аугментационной уретропластики. Урология. 2018;5:64-68. DOI: 10.18565/urology.2018.5.64-68</mixed-citation><mixed-citation xml:lang="en">Kogan M.I., Dementieva I.Yu., Mitusov V. V., Glukhov V.P., Krasulin V.V., Sizyakin D.V., Ilyash A.V. Histopathological evaluation of the evolution of oral mucosa grafts used for augmentation urethroplasty. Urology. 2018;5:64-68. (In Russian). DOI: 10.18565/urology.2018.5.64-68</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Soave A, Steurer S, Dahlem R, Rink M, Reiss P, Fisch M, Engel O. Histopathological characteristics of buccal mucosa transplants in humans after engraftment to the urethra: a prospective study. J Urol. 2014;192(6):1725-9. DOI: 10.1016/j.juro.2014.06.089</mixed-citation><mixed-citation xml:lang="en">Soave A, Steurer S, Dahlem R, Rink M, Reiss P, Fisch M, Engel O. Histopathological characteristics of buccal mucosa transplants in humans after engraftment to the urethra: a prospective study. J Urol. 2014;192(6):1725-9. DOI: 10.1016/j.juro.2014.06.089</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cavalcanti AG, Restrepo CF, Simões M, Costa WS, Sampaio FJB, de Souza DB. What Is the Best Way to Prepare A Buccal Mucosa Graft for Urethroplasty? A Histology-Based Preliminary Report. Urol Int. 2018;100(4):397-401. DOI: 10.1159/000488805</mixed-citation><mixed-citation xml:lang="en">Cavalcanti AG, Restrepo CF, Simões M, Costa WS, Sampaio FJB, de Souza DB. What Is the Best Way to Prepare A Buccal Mucosa Graft for Urethroplasty? A Histology-Based Preliminary Report. Urol Int. 2018;100(4):397-401. DOI: 10.1159/000488805</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bhattar R, Yadav SS, Tomar V. Histopathological changes in oral mucosa in cases of failed augmented urethroplasty. Turk J Urol. 2019;45(3):206-211. DOI: 10.5152/tud.2019.67435</mixed-citation><mixed-citation xml:lang="en">Bhattar R, Yadav SS, Tomar V. Histopathological changes in oral mucosa in cases of failed augmented urethroplasty. Turk J Urol. 2019;45(3):206-211. DOI: 10.5152/tud.2019.67435</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Митусов В.В., Воронова О.В., Коган М.И., Мирзаев З.А., Глухов В.П., Амирбеков Б.Г. Существует ли целесообразность фармакотерапевтической подготовки слизистой полости рта к аугментационной уретропластике? Вестник урологии. 2020;8(3):38-46. DOI: 10.21886/2308-6424-2020-8-3-38-46</mixed-citation><mixed-citation xml:lang="en">Mitusov V.V., Voronova O.V., Kogan M.I., Mirzaev Z.A., Glukhov V.P., Amirbekov B.G. Is there a feasibility of pharmacotherapeutic preparation of the oral mucosa for augmentation urethroplasty? Urology Herald. 2020;8(3):38-46. (In Russian). DOI: 10.21886/2308-6424-2020-8-3-38-46</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
